Vident Investment Advisory LLC cut its position in MetLife, Inc. (NYSE:MET) by 4.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 47,542 shares of the financial services provider’s stock after selling 2,075 shares during the quarter. Vident Investment Advisory LLC’s holdings in MetLife were worth $2,232,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also recently modified their holdings of MET. Jennison Associates LLC grew its stake in MetLife by 4.1% during the 4th quarter. Jennison Associates LLC now owns 2,912,159 shares of the financial services provider’s stock worth $136,726,000 after purchasing an additional 113,886 shares in the last quarter. Artemis Investment Management LLP grew its stake in MetLife by 8.1% during the 4th quarter. Artemis Investment Management LLP now owns 2,319,969 shares of the financial services provider’s stock worth $109,051,000 after purchasing an additional 174,522 shares in the last quarter. MUFG Securities EMEA plc lifted its holdings in MetLife by 60.8% during the 3rd quarter. MUFG Securities EMEA plc now owns 2,284,000 shares of the financial services provider’s stock worth $84,896,000 after buying an additional 864,000 shares during the last quarter. SPF Beheer BV lifted its holdings in MetLife by 9.3% during the 3rd quarter. SPF Beheer BV now owns 2,208,495 shares of the financial services provider’s stock worth $82,090,000 after buying an additional 188,090 shares during the last quarter. Finally, Alliancebernstein L.P. lifted its holdings in MetLife by 11.7% during the 4th quarter. Alliancebernstein L.P. now owns 2,159,194 shares of the financial services provider’s stock worth $101,374,000 after buying an additional 226,717 shares during the last quarter. 74.44% of the stock is owned by institutional investors and hedge funds.
In related news, CFO John D. Mccallion sold 7,456 shares of the company’s stock in a transaction that occurred on Friday, February 5th. The stock was sold at an average price of $52.22, for a total value of $389,352.32. Following the sale, the chief financial officer now owns 38,977 shares in the company, valued at approximately $2,035,378.94. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.07% of the company’s stock.
NYSE MET opened at $57.44 on Tuesday. The company has a current ratio of 0.15, a quick ratio of 0.15 and a debt-to-equity ratio of 0.21. The business’s 50 day moving average is $51.57 and its two-hundred day moving average is $44.10. MetLife, Inc. has a 12-month low of $22.85 and a 12-month high of $57.74. The stock has a market capitalization of $51.69 billion, a price-to-earnings ratio of 9.43, a PEG ratio of 1.98 and a beta of 1.35.
MetLife (NYSE:MET) last released its quarterly earnings results on Wednesday, February 3rd. The financial services provider reported $2.03 earnings per share for the quarter, topping analysts’ consensus estimates of $1.53 by $0.50. The business had revenue of $20.58 billion for the quarter, compared to analysts’ expectations of $16.12 billion. MetLife had a return on equity of 8.17% and a net margin of 8.82%. The company’s revenue was up 13.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.98 EPS. Equities analysts forecast that MetLife, Inc. will post 5.65 earnings per share for the current fiscal year.
MetLife declared that its Board of Directors has authorized a share repurchase program on Friday, December 11th that allows the company to buyback $3.00 billion in outstanding shares. This buyback authorization allows the financial services provider to buy up to 7.3% of its shares through open market purchases. Shares buyback programs are often an indication that the company’s leadership believes its stock is undervalued.
The company also recently declared a quarterly dividend, which will be paid on Monday, March 15th. Investors of record on Friday, February 5th will be issued a $0.46 dividend. This represents a $1.84 dividend on an annualized basis and a dividend yield of 3.20%. The ex-dividend date is Thursday, February 4th. MetLife’s dividend payout ratio is currently 30.11%.
MetLife Company Profile
MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.
Featured Story: What is Green Investing?
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.